https://israelnational.news/the-european-commission-provides-the-ocugen-orphan-medicinal-product-specification-for-a-gene-therapy-product-candidate-ocu400-for-the-treatment-of-both-retinitis-pigmentosa-and-congenital-leber-ama.html
The European Commission provides the Ocugen Orphan Medicinal Product Specification for a gene therapy product candidate, OCU400, for the treatment of both Retinitis Pigmentosa and Congenital Leber Amaberosis